ACOVIL

Swiss trademark · 511860 · Word mark · Deleted

Register entry

Registration number
511860
Application number
52036/2003
Status
Deleted
Type
Word mark
Filed
Jun 6, 2003
Registered
Jun 19, 2003
Published
Jul 3, 2003
Deleted
Jan 5, 2024
Reason
Not renewed
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate, nämlich Kardiovaskulärpräparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 5, 2024

    Deleted, not renewed

    Published in Swissreg on 05.01.2024

  2. May 22, 2013

    Renewed

    Published in Swissreg on 22.05.2013

  3. Nov 2, 2010

    Agent’s address changed

    Representative
    Kirker & Cie SA, Conseils en Marques, Case Postale 153,, rue de Genève 122, 1226 Thônex → Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex

    Published in Swissreg on 02.11.2010

  4. Jan 15, 2007

    Holder’s address changed

    Owner
    Aventis Pharma Deutschland GmbH, Brüningstrasse 50, 65926 Frankfurt am Main, Germany → Sanofi-Aventis Deutschland GmbH, Brüningstrasse 50, 65926 Frankfurt am Main, Germany

    Published in the SOGC no. 9 of 15.01.2007

  5. Jan 15, 2007

    Agent entered

    Representative
    Bovard AG, Patentanwälte, Optingenstrasse 16, 3000 Bern 25 → Kirker & Cie SA, Conseils en Marques, Case Postale 153,, rue de Genève 122, 1226 Thônex

    Published in the SOGC no. 9 of 15.01.2007

  6. Jul 3, 2003

    Registered

    Published in the SOGC no. 125 of 03.07.2003

Parties

Holder

Sanofi-Aventis Deutschland GmbH

Brüningstrasse 50, 65926 Frankfurt am Main, DE

Agent

Kirker & Cie SA

Kirker & Cie SA, Conseils en Marques

Rue de Genève 122, Case Postale 153, 1226 Thônex

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.